Dear Barry,

I will also be at EUROTOX next week and I would be interested to join your 
discussion. Please let me know, where and when you will meet.

Kind regards, Sylvia
-------------------------------------------------------------------------
Dr. Sylvia Escher
Fraunhofer Institute of Toxicology and Experimental Medicine (ITEM)
Chemical Risk Assessment
Group Manager Structure Activity Relationships
Nikolai-Fuchs-Strasse 1, 30625 Hannover, Germany 
Tel: +49 511 5350-330, Fax: +49 511 5350-335
mailto:Sylvia.Escher at item.fraunhofer.de
www.item.fraunhofer.de




Von:    Barry Hardy <barry.hardy at douglasconnect.com>
An:     ontology at opentox.org
Datum:  26.08.2013 11:51
Betreff:        [OpenTox Ontology] Evidence-based Toxicology Collaboration
Gesendet von:   ontology-bounces at opentox.org



The Evidence-based Toxicology Collaboration (EBTC) was formed to 
translate the principles and approaches of Evidence-based 
Medicine/Health Care to toxicology (http://www.ebtox.com/).

Open approaches to standards, data, software and ontology as promoted by 
the OpenTox Community can make a valuable contribution to the 
development of EBTC case studies applying systematic reviews in 
toxicology.

I will join Thomas Hartung and Sebastian Hoffmann at an EBTC session at 
EuroTox 2013 to discuss the development of systematic reviews in 
toxicology, which would be facilitated by a toxicology ontology.

I expect we will also communicate further details on this collaborative 
effort virtually to the community and look forward to hearing from those 
who have interest in this initiative.

Barry

Evidence-based Toxicology Collaboration
EuroTox 2013, Interlaken, Switzerland
13.00-14.00, Monday, September 2
Room: Grimsel 1+2
Chair: Thomas Hartung, USA
Evidence-based approaches, which were pioneered in medicine, provide the 
means to transparently, objectively, and consistently assess the 
evidence bearing on questions in medicine or other fields of science. 
The EBTC comprises stakeholders in academia, industry, and government 
seeking to strengthen decision-making in safety sciences, and thereby 
enhance confidence in the process by which scientific evidence is 
assessed. The EBTC is primarily interested in assessing the performance 
of the toxicological test methods and addressing questions about the 
safety of substances to human health and the environment. The EBTC’s 
efforts are timely, as there is growing interest in applying systematic 
reviews in toxicology, which would be facilitated by a toxicology 
ontology, as well as a growing recognition that new test assessment 
approaches are needed, for example in the context of composing and 
assessing integrated testing strategies.
13.00 –13.20
Evidence-based Toxicology (EBT) and the EBT Collaboration: Sebastian 
Hoffmann, Germany
13.20 –13.40
EBT and Integrated Testing Strategy: Thomas Hartung, USA
13.40–14.00
Toxicology Ontology Development supporting Evidence-based Approaches in 
Predictive Toxicology: Barry Hardy, Switzerland

_______________________________________________
Ontology mailing list
Ontology at opentox.org
http://www.opentox.org/mailman/listinfo/ontology